Hosted on MSN
GSK spin-off Haleon eyes Tylenol takeover
Haleon has lived in the shadows since it was spun off from drugs giant GlaxoSmithKline in 2022. But now the consumer healthcare firm, whose brands include Sensodyne, is on the lookout for acquisitions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results